Kamakura, Japan

Etsuro Onuma


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Tokyo, JP (1988)
  • Shizuoka, JP (2010)
  • Kamakura, JP (2013)

Company Filing History:


Years Active: 1988-2013

Loading Chart...
4 patents (USPTO):

Title: Etsuro Onuma: Innovator in Pharmaceutical Chemistry

Introduction

Etsuro Onuma is a distinguished inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. His work focuses on innovative compounds that have the potential to address various medical conditions.

Latest Patents

Onuma's latest patents include an imidazolidine derivative, which is represented by a complex chemical formula. This compound is designed to have various applications in medicine. Another notable patent involves agents for ameliorating low vasopressin levels, which includes substances that inhibit the binding between parathyroid hormone-related peptide and its receptor. These inventions showcase his commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Etsuro Onuma is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His role at the company allows him to leverage his expertise in developing new therapeutic agents. His contributions have been instrumental in the company's research and development efforts.

Collaborations

Throughout his career, Onuma has collaborated with notable colleagues such as Haruhiko Sato and Hiroshi Koga. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Etsuro Onuma's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patents reflect a dedication to improving health outcomes through scientific advancements. His contributions continue to influence the field and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…